Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Organisation › Details

Novartis Venture Fund (NVF)

The Novartis Venture Funds, established in 1996 currently manage over $750 million in committed capital. NVF invests in companies which have the potential to change a core therapeutic field or explore new business areas that will be critical to patient care. With eight investment professionals located in Basel, Switzerland and Cambridge, MA, the team has extensive experience in pharmaceutical R&D, medical devices, diagnostics and venture capital. *


Period Start 1996-01-01 established
  Group Novartis (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Murray, Campbell (Novartis 201203 Managing Director of Novartis Venture Fund)
  Person 2 Gros, Florent (Novartis 201107 Managing Director of Novartis Venture Fund)
Region Region Basel BS
  Country Switzerland
  Street Novartis International AG, P.O. Box
  City 4002 Basel
    Address record changed: 2018-08-10
Basic data Employees A: 1 to 10 (2015-01-29)
  Currency USD
  Annual sales 750,000,000 (capital, committed 2015-01-29)
    * Document for �About Section�: Atlas Genetics Ltd.. (1/29/15). "Press Release: Atlas Genetics Completes $20m Series C Fundraising. Funds to Accelerate Global Launch of Atlas io Molecular Testing System". Bath.
Record changed: 2020-08-07


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Novartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top